<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<article xml:lang="KO" article-type="research-article">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Chonnam Med J</journal-id>
<journal-id journal-id-type="publisher-id">CMJ</journal-id>
<journal-title>Chonnam Medical Journal</journal-title>
<issn pub-type="ppub">0377-9564</issn>
<publisher>
<publisher-name>Chonnam National University Medical School</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.4068/cmj.2009.45.3.182</article-id>
<article-categories>
<subj-group>
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Application of Image-Guided Radiation Therapy (IGRT) with Gold Markers in Prostate Cancer</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Jin Kuk</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Ha Jong</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Hyeong Cheol</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Kyung Ju</given-names>
</name>
<xref ref-type="aff" rid="A2">1</xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lee</surname>
<given-names>Young Goo</given-names>
</name>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

</contrib-group>

<aff id="A1">Department of Urology, Hallym University Medical College, Seoul, Korea.</aff>
<aff id="A2"><label>1</label>Department of Radio-oncology, Hallym University Medical College, Seoul, Korea.</aff>

<author-notes>
<corresp>
Corresponding author (<email>uroyglee@hanafos.com</email>)
</corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>12</month>
<year>2009</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>12</month>
<year>2009</year>
</pub-date>
<volume>45</volume>
<issue>3</issue>
<fpage>182</fpage>
<lpage>187</lpage>
<history>
<date date-type="accepted">
<day>25</day>
<month>11</month>
<year>2009</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2009 Chonnam National University Medical School</copyright-statement>
<copyright-year>2009</copyright-year>
</permissions>

<abstract>
<p>For image-guided radiation therapy (IGRT) of prostate cancer, gold markers called fiducials can be inserted into the prostate in advance. Here we examined the short-term results of IGRT for prostate cancer. We obtained the clinical data of 10 patients who underwent IGRT at the Department of Radiation Oncology in Kangnam Sacred Heart Hospital of Hallym University during March 2006 and July 2007. Three gold markers were implanted in the prostate before the radiotherapy. Exact focusing of the image was obtained by 3 gold markers on simple X-ray film or cone beam computed tomography during radiation therapy. The errors induced by setting up the patients during IGRT were examined. The setup errors, averaged over all patients, were -0.88 mm, 1.85 mm, and -0.40 mm in the left-right, cranial-caudal, and anterior-posterior directions, respectively. The motion of the prostate was greatest in the cranial-caudal (6.5 mm) direction. The post-radiation therapy prostate-specific antigen (PSA) level was decreased dramatically in all 10 patients. Two of three patients who had received hormonal therapy with IGRT showed a PSA nadir 12 months later without hormonal therapy. There were no peri-radiotherapy complications. Through the use of IGRT with gold markers, we could correct the setup errors that occur in conventional radiation therapy. Post-IGRT PSA was decreased dramatically. Even though our data are limited, we suggest that IGRT may be an effective radiation therapy modality for decreasing peri-radiotherapy complications and improving radiotherapy results in prostate cancer through exact focusing of the radiation.</p>
</abstract>

<kwd-group>
<kwd>Prostatic neoplasms</kwd>
<kwd>Gold compounds</kwd>
<kwd>Radiotherapy</kwd>
</kwd-group>
</article-meta>
</front>

<back>

<ref-list>

  <ref id="B1">
    <label>1</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Bak</surname>
          <given-names>JH</given-names>
        </name>
        <name>
          <surname>Jeong</surname>
          <given-names>KK</given-names>
        </name>
        <name>
          <surname>Keum</surname>
          <given-names>KC</given-names>
        </name>
        <name>
          <surname>Park</surname>
          <given-names>SW</given-names>
        </name>
      </person-group>
      <article-title>On-line image guided radiation therapy using cone-beam CT (CBCT)</article-title>
      <source>J Korean Soc Ther Radiol Oncol</source>
      <year>2006</year>
      <volume>24</volume>
      <fpage>294</fpage>
      <lpage>299</lpage>
    </nlm-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Burman</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Chui</surname>
          <given-names>CS</given-names>
        </name>
        <name>
          <surname>Kutcher</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Leibel</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Zelefsky</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>LoSasso</surname>
          <given-names>T</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>1997</year>
      <volume>39</volume>
      <fpage>863</fpage>
      <lpage>873</lpage>
    </nlm-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>De Meerleer</surname>
          <given-names>GO</given-names>
        </name>
        <name>
          <surname>Vakaet</surname>
          <given-names>LA</given-names>
        </name>
        <name>
          <surname>De Gersem</surname>
          <given-names>WR</given-names>      
        </name>
        <name>
          <surname>De Wagter</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>De Naeyer</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>De Neve</surname>
          <given-names>W</given-names>
        </name>
      </person-group>
      <article-title>Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2000</year>
      <volume>47</volume>
      <fpage>639</fpage>
      <lpage>648</lpage>
    </nlm-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Zelefsky</surname>
          <given-names>MJ</given-names>
        </name>
        <name>
          <surname>Fuks</surname>
          <given-names>Z</given-names>
        </name>
        <name>
          <surname>Happersett</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>HJ</given-names>
        </name>
        <name>
          <surname>Ling</surname>
          <given-names>CC</given-names>
        </name>
        <name>
          <surname>Burman</surname>
          <given-names>CM</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer</article-title>
      <source>Radiother Oncol</source>
      <year>2000</year>
      <volume>55</volume>
      <fpage>241</fpage>
      <lpage>249</lpage>
    </nlm-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Nutting</surname>
          <given-names>CM</given-names>
        </name>
        <name>
          <surname>Convey</surname>
          <given-names>DY</given-names>
        </name>
        <name>
          <surname>Cosgrove</surname>
          <given-names>VP</given-names>
        </name>
        <name>
          <surname>Rowbottom</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Padhani</surname>
          <given-names>AR</given-names>
        </name>
        <name>
          <surname>Webb</surname>
          <given-names>S</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2000</year>
      <volume>48</volume>
      <fpage>649</fpage>
      <lpage>656</lpage>
    </nlm-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Van Herk</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Errors and margins in radiotherapy</article-title>
      <source>Semin Radiat Oncol</source>
      <year>2004</year>
      <volume>14</volume>
      <fpage>52</fpage>
      <lpage>64</lpage>
    </nlm-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hong</surname>
          <given-names>JY</given-names>
        </name>
        <name>
          <surname>Rah</surname>
          <given-names>JE</given-names>
        </name>
        <name>
          <surname>Suh</surname>
          <given-names>TS</given-names>
        </name>
      </person-group>
      <article-title>A study on image reconstruction for seed localization for permanent prostate brachytherapy</article-title>
      <source>J Korean Soc Ther Radiol Oncol</source>
      <year>2007</year>
      <volume>25</volume>
      <fpage>125</fpage>
      <lpage>133</lpage>
    </nlm-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Langen</surname>
          <given-names>KM</given-names>
        </name>
        <name>
          <surname>Zhang</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Andrews</surname>
          <given-names>RD</given-names>
        </name>
        <name>
          <surname>Hurley</surname>
          <given-names>ME</given-names>
        </name>
        <name>
          <surname>Meeks</surname>
          <given-names>SL</given-names>
        </name>
        <name>
          <surname>Poole</surname>
          <given-names>DO</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Initial experience with megavoltage (MV) CT guidance for daily prostate alignments</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2005</year>
      <volume>62</volume>
      <fpage>1517</fpage>
      <lpage>1524</lpage>
    </nlm-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Moseley</surname>
          <given-names>DJ</given-names>
        </name>
        <name>
          <surname>White</surname>
          <given-names>EA</given-names>
        </name>
        <name>
          <surname>Wiltshire</surname>
          <given-names>KL</given-names>
        </name>
        <name>
          <surname>Rosewall</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Sharpe</surname>
          <given-names>MB</given-names>
        </name>
        <name>
          <surname>Siewerdsen</surname>
          <given-names>JN</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2007</year>
      <volume>67</volume>
      <fpage>942</fpage>
      <lpage>953</lpage>
    </nlm-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hurkmans</surname>
          <given-names>CW</given-names>
        </name>
        <name>
          <surname>Remeijer</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Lebesque</surname>
          <given-names>JV</given-names>
        </name>
        <name>
          <surname>Mijnheer</surname>
          <given-names>BJ</given-names>
        </name>
      </person-group>
      <article-title>Set-up verification using portal imaging: review of current clinical practice</article-title>
      <source>Radiother Oncol</source>
      <year>2001</year>
      <volume>58</volume>
      <fpage>105</fpage>
      <lpage>120</lpage>
    </nlm-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Welsh</surname>
          <given-names>JS</given-names>
        </name>
        <name>
          <surname>Berta</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Borzillary</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Sam</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Shickell</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Nobile</surname>
          <given-names>L</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy</article-title>
      <source>Technol Cancer Res Treat</source>
      <year>2004</year>
      <volume>3</volume>
      <fpage>359</fpage>
      <lpage>364</lpage>
    </nlm-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Henry</surname>
          <given-names>AM</given-names>
        </name>
        <name>
          <surname>Stratford</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Davies</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>McCarthy</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Swindell</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Sykes</surname>
          <given-names>J</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device</article-title>
      <source>Br J Radiol</source>
      <year>2005</year>
      <volume>78</volume>
      <fpage>737</fpage>
      <lpage>741</lpage>
    </nlm-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <nlm-citation citation-type="confproc">
      <person-group person-group-type="author">
        <name>
          <surname>Gladstone</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Hartford</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Marshall</surname>
          <given-names>J</given-names>
        </name>
      </person-group>
      <source>Gold coils used as fiducial markers of prostate location for image guided radiotherapy</source>
      <year>2005</year>
      <conf-name>Radiological Society of North America 2005 Annual Meeting</conf-name>
      <conf-loc>Chicago</conf-loc>
    </nlm-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Huisman</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>F&#x00FC;tterer</surname>
          <given-names>JJ</given-names>
        </name>
        <name>
          <surname>van Lin</surname>
          <given-names>EN</given-names>
        </name>
        <name>
          <surname>Welmers</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Scheenen</surname>
          <given-names>TW</given-names>
        </name>
        <name>
          <surname>van Dalen</surname>
          <given-names>JA</given-names>
        </name>
      </person-group>
      <article-title>Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers</article-title>
      <source>Radiology</source>
      <year>2005</year>
      <volume>236</volume>
      <fpage>311</fpage>
      <lpage>317</lpage>
    </nlm-citation>
  </ref>

  <ref id="B15">
    <label>15</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Shimizu</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Shirato</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Kitamura</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Shinohara</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Harabayashi</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Tsukamoto</surname>
          <given-names>T</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2000</year>
      <volume>48</volume>
      <fpage>1591</fpage>
      <lpage>1597</lpage>
    </nlm-citation>
  </ref>

  <ref id="B16">
    <label>16</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hanks</surname>
          <given-names>GE</given-names>
        </name>
        <name>
          <surname>Hanlon</surname>
          <given-names>AI</given-names>
        </name>
        <name>
          <surname>Epsten</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Horwitz</surname>
          <given-names>EM</given-names>
        </name>
      </person-group>
      <article-title>Dose response in prostate cancer with 8-12 years' follow-up</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2002</year>
      <volume>54</volume>
      <fpage>427</fpage>
      <lpage>435</lpage>
    </nlm-citation>
  </ref>

  <ref id="B17">
    <label>17</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Meyer</surname>
          <given-names>JL</given-names>
        </name>
        <name>
          <surname>Leibel</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Roach</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Vijayakumar</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>New technologies for the radiotherapy of prostate cancer. A discussion of clinical treatment programs</article-title>
      <source>Front Radiat Ther Oncol</source>
      <year>2007</year>
      <volume>40</volume>
      <fpage>315</fpage>
      <lpage>337</lpage>
    </nlm-citation>
  </ref>

  <ref id="B18">
    <label>18</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Fisch</surname>
          <given-names>BM</given-names>
        </name>
        <name>
          <surname>Pickett</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Weinberg</surname>
          <given-names>V</given-names>
        </name>
        <name>
          <surname>Roach</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer</article-title>
      <source>Urology</source>
      <year>2001</year>
      <volume>57</volume>
      <fpage>955</fpage>
      <lpage>959</lpage>
    </nlm-citation>
  </ref>

  <ref id="B19">
    <label>19</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Roach</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Winter</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Michalski</surname>
          <given-names>JM</given-names>
        </name>
        <name>
          <surname>Cox</surname>
          <given-names>JD</given-names>
        </name>
        <name>
          <surname>Purdy</surname>
          <given-names>JA</given-names>
        </name>
        <name>
          <surname>Bosch</surname>
          <given-names>W</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2004</year>
      <volume>60</volume>
      <fpage>1351</fpage>
      <lpage>1356</lpage>
    </nlm-citation>
  </ref>

  <ref id="B20">
    <label>20</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Kuban</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Pollack</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Huang</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Levy</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Dong</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Starkschall</surname>
          <given-names>G</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Hazards of dose escalation in prostate cancer radiotherapy</article-title>
      <source>Int J Radiat Oncol Biol Phys</source>
      <year>2003</year>
      <volume>57</volume>
      <fpage>1260</fpage>
      <lpage>1268</lpage>
    </nlm-citation>
  </ref>

</ref-list>

</back>

<floats-wrap>

<fig position="float" id="F1">
<label>Fig. 1</label>
<caption>
  <p>Cliax iX with Cone-Beam CT.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-g001" alt-version="no"></graphic>
</fig>

<fig position="float" id="F2">
<label>Fig. 2</label>
<caption>
  <p>(A) Gold marker positions are Mkr1, Mkr2 and Mkr3 in the right base, left lateral and right apex of prostate. (B) Doctors may insert gold marker into the prostate by placing hollow gold needles through the rectum and moving a fiducial through each needle.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-g002" alt-version="no"></graphic>
</fig>

<fig position="float" id="F3">
<label>Fig. 3</label>
<caption>
  <p>Simple X-ray image showing three gold marker seeds.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-g003" alt-version="no"></graphic>
</fig>

<fig position="float" id="F4">
<label>Fig. 4</label>
<caption>
  <p>(A) The CT image showing significant displacement of simulation CT and cone-beam CT images. (B) Fused image was corrected with displacement vector components.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-g004" alt-version="no"></graphic>
</fig>

<fig position="float" id="F5">
<label>Fig. 5</label>
<caption>
  <p>Shifts along the principal directions of x-axis, y-axis and z-axis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-g005" alt-version="no"></graphic>
</fig>

<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption>
  <p>Characteristics of the patients</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-i001" alt-version="no"></graphic>
<table-wrap-foot>
<fn>
  <p><sup>&#x002A;</sup>Prostate vol. (ml), Prostate volume (ml); <sup>&#x2020;</sup>PSA, 2 months later; <sup>&#x2021;</sup>Hormone therapy.</p>
</fn>
</table-wrap-foot>
</table-wrap>

<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption>
  <p>Relationship of the setup errors with prostate volume</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmj-45-182-i002" alt-version="no"></graphic>
</table-wrap>

</floats-wrap>

</article>